โรคมะเร็งต่อมน้ำเหลืองฮอดจ์กินที่มาด้วยอาการซีดอย่างรุนแรงและตับม้ามโต: รายงานผู้ป่วยเด็ก 2 ราย

Authors

  • เจน เจิดอำไพ Chiang Mai University
  • ลลิตา สาธิตสมิตพงษ์ Chiang Mai University
  • รุ่งโรจณ์ เนตรศิรินิลกุล Chiang Mai University
  • กานดา ฝั้นจักสาย Chiang Mai University
  • พิมพ์ลักษณ์ เจริญขวัญ Chiang Mai University

Keywords:

anemia, Hodgkin lymphoma, children, splenomegaly, prolonged fever

Abstract

Although anemia is commonly found among patients with Hodgkin lymphoma, the severity is usually mild. We herein report a 9-year-old Hmong boy and a 5-year-old Tai-Yai girl presenting worsening anemia, prolonged fever and hepatosplenomegaly. The first patient had progressive anemia for 8 months and later required monthly transfusion. Physical examination revealed anemia, left supraclavicular lymphadenopathy, enlarged liver and markedly enlarged spleen. Laboratory investigation showed a hemoglobin level of 5.3 g/dL and normal white blood cell and platelet counts. The direct and indirect antiglobulin tests (DAT and IAT) were negative. The second patient had anemia, bilateral cervical lymphadenopathies and enlarged liver and spleen. The hemoglobin level was 8.0 g/dL while white blood cell and platelet counts were normal. The DAT and IAT were positive. An excisional lymph node biopsy showed Reed-Sternberg cells on hematoxylin and eosin stain. The patients were diagnosed with classical Hodgkin lymphoma stage IIIS-B and stage IVS-B, respectively. The second patient received chemotherapy, corticosteroid and radiotherapy and responded well. Severe anemia and splenomegaly could be one presentation of Hodgkin lymphoma.

Downloads

Download data is not yet available.

References

1. Shenoy P, Maggioncalda A, Malik N, Flowers CR. Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States. Adv Hematol. 2011;2011:725219.
2. Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12:2215-20.
3. Bazzeh F, Rihani R, Howard S, Sultan I. Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005: an analysis of 21 734 cases. Leuk Lymphoma. 2010;51:2198-207.
4. Hohaus S, Massini G, Giachelia M,Vannata B, Bozzoli V, Cuccaro A, et al. Anemia in Hodgkin’s lymphoma: The role of interleukin-6 and hepcidin. J Clin Oncol. 2010;28:2538-43.
5. Metzger M, Krasin MJ, Hudson MM, Onciu M. Hodgkin Lymphoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 638-62
6. Thai Pediatric Oncology Group. National protocol for treatment of childhood cancer 2016. Bangkok: M Print Corporation; 2016.
7. Friedman DL. Hodgkin Lymphoma. In: Lanzkowsky P, Lipton JM, Fish JD, editors. Lanzkowsky’s manual of pediatric hematology and oncology. 6th ed. London: Elsevier Academic press; 2016. p. 429-41.
8. Lechner K, Chen YA. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma. Leuk Lymphoma. 2010;51:469-74.
9. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell. 2007;130:25-35.
10. Poppema S, Maggio E, van den Berg A. Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma. 2004;45:423-31.
11. Cecinati V, Brugnoletti F, D’Angio M, De Nicolò MC, De Vellis A, Coluzzi S, et al. Autoimmune hemolytic anemia and immune thrombocytopenia as unusual presentations of childhood Hodgkin lymphoma: a case report and review of the literature. J Pediatr Hematol Oncol. 2012;34:280-2.
12. Englund A, Glimelius I, Rostgaard K, Smedby KE, Eloranta S, Molin D, et al. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome. Acta Oncol. 2018;57:276-82.
13. Jorgov L, Montravers F, Balogova S, Ragu C, Pacquement H, Leblanc T, et al. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT. Eur J Nucl Med Mol Imaging. 2016;43:1220-30.
14. Arya LS, Dinand V, Bakhshi S, Thavaraj V, Singh R, Dawar R. Significance of splenomegaly in childhood Hodgkin disease. J Pediatr Hematol Oncol. 2004;26:807-12.
15. Kupatawintu P, Emthip M, Sungnoon D, O-vataga P, Manakul V, Limtamaporn S, et al. Unexpected Antibodies of Patients, Blood Samples Sent for Testing at NBC. TRCS. J Hematol Transfus Med 2010;20:255-62

Downloads

Published

2019-12-23

Issue

Section

รายงานผู้ป่วย (Case report)